Home Procurement NewsEli Lilly to acquire obesity drug maker Versanis for $1.9 billion

Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion

July 14, 2023•

The deal is Eli Lilly’s latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk’s Wegovy and Ozempic.

Was this article helpful?

YesNo

Last modified: July 14, 2023

Previous: Lagos alone accounts for over N328billion investment, forex, BEC scams in Nigeria – EFCC boss

Next: Court discharges Okorocha of alleged N2.9 billion corruption charges

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships